| [1] |
LIU Jiayun, GAO Guomin, LI Xiaojin, FAN Huiping, WANG Xing, ZHANG Dong, MA Weiyuan.
Analysis of clinical efficacy of tofacitinib in the treatment of papulopustular rosacea
[J]. China Journal of Leprosy and Skin Diseases, 2026, 42(3): 168-171.
|
| [2] |
HUA Lingyun, XIA Rushan.
Application of JAK inhibitors in rosacea
[J]. China Journal of Leprosy and Skin Diseases, 2026, 42(1): 67-70.
|
| [3] |
QU Peng, LIU Yongxia, WANG Guangjin.
Tofacitinib in the treatment of refractory rosacea: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2025, 41(9): 682-684.
|
| [4] |
ZHOU Meng, SUO Panpan, LIU Baoguo, LYU Chao, WANG Xin, MIAO Guoying.
Efficacy of biological agents or small molecular targeted drugs in the treatment of 6 cases with refractory pityriasis rubra pilaris
[J]. China Journal of Leprosy and Skin Diseases, 2025, 41(8): 583-586.
|
| [5] |
YAO Xinyi, GE Man, LIU Lyuye, ZHANG Junling.
Efficacy and safety of apremilast in the treatment of palmoplantar pustulosis
[J]. China Journal of Leprosy and Skin Diseases, 2025, 41(6): 429-432.
|
| [6] |
LIU Wenhui, CHEN Shengli, SHI Zhongxiang, LIU Hong.
Hailey-Hailey disease successfully treated with apremilast: two cases report and literature review
[J]. China Journal of Leprosy and Skin Diseases, 2025, 41(3): 180-183.
|
| [7] |
LI Huijie, JIAO Yuzhu, YANG Qing.
Off-label uses of apremilast in dermatology
[J]. China Journal of Leprosy and Skin Diseases, 2025, 41(1): 79-83.
|
| [8] |
WANG Na, YANG Qing.
Apremilast used in one case of palmoplantar pustulosis
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(8): 565-567.
|
| [9] |
LYU Shuang, FU Xi'an, SHI Zhongxiang, YUE Zhenhua, ZHANG Huimin, LIU Hong, ZHANG Furen.
Hydroxychloroquine induced lip mucosal hyperpigmentation: three cases report
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(7): 484-487.
|
| [10] |
JIANG Yumeng, ZHOU Zhonglian, CHEN Mingliang, LI Fangfang, XIE Hongfu, HUANG Yingxue.
Nasal Langerhans cell histiocytosis: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(7): 504-505.
|
| [11] |
MENG Xiaoqi, LIU Tingwei, GU Duoduo, PAN Ruoxin, ZHANG Yue, XU Yang.
Update of treatment of rosacea
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(6): 450-456.
|
| [12] |
QU Peng, ZHAO Wei, ZHANG Fan, LIU Yongxia, WANG Guangjin.
Apremilast in the treatment of oral lichen planus: a case report and literature review
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(11): 778-780.
|
| [13] |
XU Fanli, CHEN Mingfei.
Alopecia areata treated with apremilast: a case report and literature review
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(10): 708-711.
|
| [14] |
DUAN Meng, DONG Bingqi, LIAO Zhikai, LEI Tiechi.
Stimulation of cathelicidin in cultured human keratinocytes by Substance P via the activation of nuclear factor NF-κB
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(6): 403-408.
|
| [15] |
GU Duoduo, PAN Ruoxin, ZHANG Yue, LI Min, TAO Meng, XU Yang.
Update of the mast cells and mast cell stabilizers in pathogenesis and treatment of rosacea
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(6): 451-455.
|